Evidence map›Paper›PMID 42315941›Full record

ArticleScientific reports2026

Molecular diversity and evolutionary dynamics of phage receptor binding proteins in Staphylococcus aureus: implications for phage therapy and resistance.

C S VinodKumar, B S Prasad, A Arunkumar, Ishfaq Nabi Najar, Aarti Singh, J K Veni Emilda, R Venkatesh, Vikram Sivaji, V L Jayasimha, Suresh Basavaraj Arakera and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

C S VinodKumarCentre for Excellence in Bacteriophage Innovation, Department of Microbiology, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India. vinodmicro@gmail.com.ORCID https://orcid.org/0000-0001-8029-9302
B S PrasadDepartment of Paediatrics, S.S. Institute of MedicalSciences and Research Centre, Davangere, Karnataka, India.
A ArunkumarDepartment of Anaesthesia, S.S. Institute of MedicalSciences and Research Centre, Davangere, Karnataka, India.
Ishfaq Nabi NajarCentre for Excellence in Bacteriophage Innovation, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
Aarti SinghCentre for Excellence in Bacteriophage Innovation, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
J K Veni EmildaCentre for Excellence in Bacteriophage Innovation, Department of Microbiology, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
R VenkateshCentre for Excellence in Bacteriophage Innovation, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
Vikram SivajiCentre for Excellence in Bacteriophage Innovation, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
V L JayasimhaCentre for Excellence in Bacteriophage Innovation, Department of Microbiology, S. S. Institute of Medical Science and Research Centre, Davangere, Karnataka, India.
Suresh Basavaraj ArakeraDepartment of Applied Genetics, Karnatak University, Dharwad, Karnataka, India.
Suneeta KalasuramathDepartment of Physiology, S.S. Institute of Medical Sciences and Research Centre, Davangere, Karnataka, India.
N RameshCentre for Advanced Research in Bacteriophage and Infectious Diseases, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Balaji VeeraraghavanDepartment of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.

Funding

Indian Council of Medical Research CAR/ICMRCAREP-2023/0000138/2023
6 · The paper itself

Abstract

Phage-host interactions are defined by the molecular specificity of receptor-binding proteins (RBPs), which determine the efficacy of infection and the host range. The genetic and structural variability of bacterial receptor molecules is essential for designing effective phage therapeutics and mitigating resistance. This study investigated four receptor-binding proteins, tarS, tarL, tagO, and tagG, in multiple Staphylococcus aureus isolates. Single-nucleotide polymorphism (SNP) analysis was performed to assess receptor diversity and evolutionary conservation. Molecular docking was conducted between these bacterial receptors and Staphylococcus phage tail and spike proteins (TPCARΦ38, TPCARΦ53, TSCARΦ53, and SPCARΦ58) to evaluate binding affinity and interaction specificity. SNP profiling revealed conserved and strain-specific mutations across the receptor genes, predominantly transition-type substitutions, without insertions or deletions. Docking simulations demonstrated strong receptor-phage interactions, with binding energies ranging from 8 to 14 kcal/mol. Despite underlying genetic variation, conserved docking hotspots suggested functional stability and evolutionary pressure to preserve key receptor-binding motifs essential for phage attachment. The findings indicate a coevolutionary balance between S. aureus receptor polymorphism and phage adaptation. Such receptor diversity may drive partial resistance while maintaining susceptibility to related phages. This molecular understanding of RBP evolution provides valuable insights for designing rational, broad-spectrum, or combination phage therapy strategies against S. aureus infections.

Indexed as

Bacterial ProteinsBacteriophage ReceptorsEvolution, MolecularPhage TherapyStaphylococcus aureusStaphylococcus PhagesGenetic VariationMolecular Docking SimulationPolymorphism, Single NucleotideProtein BindingStaphylococcal InfectionsBacterial ProteinsBacteriophage ReceptorsBacteriophageMolecular dockingPhage–host coevolutionPhage resistanceReceptor-binding proteinSNP analysisStaphylococcus aureusTherapeutic phage designWall teichoic acid

Identifiers

PMID42315941
PMCPMC13550422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.